← Eichor
Study identifier: NCT07370350 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ultrasound Assessment of Tongue Characteristics in Children and Adolescents With Obesity

Condition: Obesity & Overweight · Pediatric Obesity · Obstructive Sleep Apnea (OSA)  ·  Sponsor: Haute Ecole Bruxelles-Brabant

PhaseN/A
Planned participants100
Who can joinAll sexes, 6 Years to 18 Years
Healthy volunteersYes

About this study

This longitudinal observational study aims to validate ultrasound-based tongue markers related to tongue characteristics, including fat accumulation, morphologic and mechanical properties of the tongue in children and adolescents with obesity. Participants are assessed at baseline and after completion of a standardized 30-week inpatient weight-loss rehabilitation program at the Zeepreventorium (De Haan, Belgium). Tongue ultrasound parameters are examined in relation to anthropometric characteristics and obstructive sleep apnea condition.

This description comes directly from the study's public registry record.

Talk to the study team

Frederic Paillaugue, MSc PT  ·  +32485952930  ·  frederic.paillaugue@vub.be

Always discuss trial participation with your own doctor first.

Locations (2)

ISEK-HE2B, av. Schalle 91Brussels, BelgiumRecruiting
Zeepreventorium Koninklijke Baan 5De Haan, BelgiumNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07370350